Why Invest in Hi-Tech Parks
Impressive Economic Performance :
Bangladesh, growing rapidly over a decade, is on its way to becoming the next
Asian Tiger. Economic and political stability are driving its journey towards the
future. The economy has grown at an average rate of 7% percent during the five
years even in the Covid-19 pandemic situation. The per capita GNI in FY 2020-
2021 was USD 2,227. The country has USD 44 billion in Foreign Exchange reserve.
Currently the 41st largest economy, Bangladesh will be the 25th largest economy
Liberal Pro-Business Policies:
Pro-market policies embedded within the government’s economic vision
contribute to a strong, liberal and transparent trading and commercial environment.
In its drive to build a strong and stable economy the government has implemented
several policies that opens up attractive opportunities and incentives for foreign
Diversification in Investment:
Bangladesh is committed to further diversifying its economy by facilitating
investment in targeted sectors such as Hi- Tech Electronics, Software Technology,
Bio-Technology, Green Technology, Renewable Energy, Hardware Manufacturing,
IT/ITES, R&D etc. There is great opportunity to invest in new technologies and
unique solutions in a variety of economic sectors to maximize the economic
advantages presented by its location, beauty, infrastructure and human capital.
Ease of Doing Business:
Huge efforts have been made to improve the ease of doing business in the
country. The formalities and processes for registration and operations of foreign
investments have been streamlined through changes in laws and regulations, and
well-defined procedures, designed to offer clarity, security, convenience and speed
for investors looking at investing in the country.
Enlisted among the next 10 Emerging Markets (Coface)
Lowest cost of operations, among the top 250 Investment Destinations
globally (Everest Group)
The most optimistic market among 34 markets globally (HSBC)
Over 3 billion dollars market in software, hardware, mobile and bio-tech
with a constant growth, even in COVID-19